8.78
-0.20 (-2.23%)
| Penutupan Terdahulu | 8.98 |
| Jumlah Dagangan | 66,955 |
| Harga / Pendapatan (P/E Ke hadapan) | 12.15 |
| Harga / Jualan (P/S) | 5.62 |
| Harga / Buku (P/B) | 4.62 |
| Julat 52 Minggu |
| Margin Keuntungan | 9.01% |
| Margin Operasi (TTM) | 4.99% |
| EPS Cair (TTM) | 0.220 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 26.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 897.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 8.73% |
| Nisbah Semasa (MRQ) | 5.03 |
| Aliran Tunai Operasi (OCF TTM) | 12.13 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 3.66 M |
| Pulangan Atas Aset (ROA TTM) | 1.42% |
| Pulangan Atas Ekuiti (ROE TTM) | 7.41% |
Sentimen Berita
AISkor Stockmoo
| Nilai 30% | 3.2 |
| Harga rendah berbanding pertumbuhan perolehannya. info | |
| Pulangan di bawah kos modalnya. Pulangan atas modal meningkat. info | |
| Hutang rendah. Keuntungan lemah. Kecairan jangka pendek mencukupi. Aliran tunai positif. info | |
| Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info | NA |
| Pertumbuhan Tersirat info | NA |
| Sejarah Penilaian info | NA |
| Nilai Pegangan info | NA |
| Premium Risiko info | NA |
| Penilaian Pasaran info | NA |
| Masa 30% | -3.2 |
| Aliran menaik sepanjang tahun lalu. Jauh di bawah paras tertinggi 52 minggu. info | |
| Aliran menurun: harga di bawah purata bergeraknya, dan purata itu sedang menurun. Harga telah jatuh jauh di bawah purata itu. Dagangan lebih tinggi pada hari harga turun. info | |
| Daripada analisis teknikal AI kami terhadap carta. info | NA |
| Corak Lilin info | NA |
| Sentimen 20% | 1.4 |
| Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info | |
| Berita terkini kebanyakannya positif. info | |
| Sentimen Pegangan info | NA |
| Wang Pintar 20% | 1.2 |
| Institusi bersih +0.96% daripada saham dalam pemfailan 13F terkini: 32 pemegang menambah, 27 mengurang (suku berakhir 30 Sep 2026). info | |
| Kedudukan jual singkat -4.2% dari 31 Aug hingga 30 Oct 2026, 2.5 hari untuk tutup (FINRA). info | |
| Aktiviti Orang Dalam info | NA |
| Keadaan pasaran dan sektor lemah. | |
| Persekitaran pasaran berhati-hati. info | |
| Sektor ketinggalan berbanding pasaran. | |
| Tonggak-tonggak tidak sependapat, jadi skor dilemahkan. | |
| Tidak dikira dalam skor | |
| Di bawah garis aliran jangka sederhana. info | |
| Harga rendah berbanding purata 52 minggunya. Naik dalam tempoh 5 tahun. info | |
| Aliran turun bagi ketiga-tiga tempoh. Momentum jangka pendek menurun. info | |
| Tiada isyarat jelas daripada sokongan dan rintangan. info | |
| Skor Akhir | 0.40 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Brainsway Ltd. | Bercampur | Menurun |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B | Skor |
|---|---|---|---|---|---|
| BWAY | - | - | - | 4.62 | 0.4 |
| SSII | - | - | - | 6.11 | -2.0 |
| QTI | - | - | - | 9.14 | -5.0 |
| AXGN | - | - | - | 6.12 | 0.0 |
| ESTA | - | - | - | 128.59 | -1.7 |
| NMTC | - | - | - | 1.80 | -0.3 |
|
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 6.40% |
| % Dimiliki oleh Institusi | 32.27% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Valor Management Llc | 30 Sep 2026 | 5,314,950 |
| Masters Capital Management Llc | 30 Sep 2026 | 1,246,099 |
| Essex Investment Management Co Llc | 30 Sep 2026 | 574,818 |
| Cresset Asset Management, Llc | 30 Sep 2026 | 314,924 |
| Hwg Holdings Lp | 30 Sep 2026 | 253,050 |
| Y.D. More Investments Ltd | 30 Sep 2026 | 224,382 |
| Eagle Global Advisors Llc | 30 Sep 2026 | 182,606 |
| Legato Capital Management Llc | 30 Sep 2026 | 176,569 |
| Ark Investment Management Llc | 30 Sep 2026 | 146,850 |
| Sei Investments Co | 30 Sep 2026 | 119,717 |
| Walleye Capital Llc | 30 Sep 2026 | 106,834 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Institusi
Pemilikan institusi: 28.39%
| Kedudukan | Pemegang | Saham |
|---|---|---|
| Bertambah | 32 | 715,233 |
| Berkurang | 27 | 782,187 |
| Baharu | 20 | 567,025 |
| Dijual habis | 8 | 116,475 |
Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.
Kedudukan Jual Singkat
| Penyelesaian | Saham | Hari untuk tutup |
|---|---|---|
| 30 Oct 2026 | 199,353 | 2.5 |
| 15 Oct 2026 | 226,033 | 1.7 |
| 30 Sep 2026 | 250,485 | 2.8 |
| 15 Sep 2026 | 199,566 | 2.2 |
| 31 Aug 2026 | 208,111 | 2.5 |
| 14 Aug 2026 | 156,367 | 1.0 |
Data jual singkat FINRA melalui Nasdaq, dilaporkan dua kali sebulan.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 10 Nov 2026 | Yahoo Finance |
BrainsWay Ltd (BRSYF) (Q3 2026) Earnings Call Highlights: Revenue Jumps 34% as Margins Expand ...
BrainsWay Ltd (BRSYF) posted $18.1 million in Q3 2026 revenue, doubled operating income to $2.6 million, and signaled full-year results at the high end of guidance on strong SWIFT and OCD demand. |
| 10 Nov 2026 | Yahoo Finance |
What Brainsway (BWAY) Said on Its Q3 Earnings Call
Brainsway (NASDAQ:BWAY) reported 34% revenue growth and a more than doubling of operating income in the third quarter of 2026, as shipments of its Deep TMS systems increased and reimbursement coverage expanded for its accelerated treatment protocol. The company expects full-year results to land at… |
| 10 Nov 2026 | Yahoo Finance |
BrainsWay Reports Third Quarter 2026 Financial Results and Operational Highlights
Revenue increased 34% to $18.1 million in Q3 2026; Operating income rose 107% to $2.6 million and Adjusted EBITDA rose approximately 92% to $3.9 million Remaining performance obligations grew 31% year-over-year to approximately $85 million Shipped 130 Deep TMS systems in Q3 2026, a 44% increase… |
| 02 Nov 2026 | Yahoo Finance |
BrainsWay Announces Strategic Collaboration with Mindful Health Solutions
Latest Collaboration Comes Amid Progress in Other Strategic Initiatives, Including Follow-on Investment in Earlier Minority Stake Investment TargetBURLINGTON, Mass. and JERUSALEM, Nov. 02, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader… |
| 28 Oct 2026 | Yahoo Finance |
BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026
BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced non-invasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter 2026… |
| 26 Oct 2026 | Yahoo Finance |
BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
BURLINGTON, Mass. and JERUSALEM, Oct. 26, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced further expansion in the number of medical policies across the U.S.… |
| 19 Oct 2026 | Yahoo Finance |
BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group
Partnership with Established Southern California Behavioral Health Provider Aims to Accelerate Innovative Application of Interventional Psychiatry TreatmentsBURLINGTON, Mass. and JERUSALEM, Oct. 19, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a… |
| 13 Oct 2026 | Yahoo Finance |
BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives
BURLINGTON, Mass. and JERUSALEM, Oct. 13, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced further expansion in the number of medical policies across the U.S.… |
| 10 Sep 2026 | Yahoo Finance |
BrainsWay’s (BWAY) Growth Streak Just Got Harder To Ignore
On August 12, BrainsWay Ltd. (NASDAQ:BWAY) reported second-quarter 2026 results that make the neurostimulation company look less like a niche medtech story and more like a genuine growth compounder. Revenue climbed 35% year over year to a record $17.1 million, and adjusted EBITDA more than doubled… |
| 09 Sep 2026 | Yahoo Finance |
Are Options Traders Betting on a Big Move in Brainsway Stock?
Investors need to pay close attention to BWAY stock based on the movements in the options market lately. |
| 08 Sep 2026 | Yahoo Finance |
BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
Peer-reviewed pilot study shows 83.3% response rate and 50% remission rate in depressive symptoms, alongside measurable neurophysiological changes in brain activity and connectivity BURLINGTON, Mass. and JERUSALEM, Sept. 08, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global… |
| 27 Aug 2026 | Yahoo Finance |
Wall Street Analysts See a 30.07% Upside in Brainsway (BWAY): Can the Stock Really Move This High?
The mean of analysts' price targets for Brainsway (BWAY) points to a 30.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. |
| 27 Aug 2026 | Yahoo Finance |
BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation
Peer-reviewed secondary analysis adds to growing body of clinical evidence supporting the potential role of Deep TMS in addressing suicidal ideation among patients with major depressive disorderBURLINGTON, Mass. and JERUSALEM, Aug. 27, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY)… |
| Papar semua | ||
Isyarat Terkini corak lilin dan silang EMA
Persediaan Teknikal Sederhana
AI Analisis Teknikal
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |